Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients

Clinical Journal of the American Society of Nephrology

Volumn 5, Issue 4, 2010, Pages 683-692

  Noori, Nazanin ^a   Kalantar Zadeh, Kamyar ^a,b   Kovesdy, Csaba P ^c   Bross, Rachelle ^a   Benner, Debbie ^d   Kopple, Joel D ^a,b  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d DaVita Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; PHOSPHORUS; PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UREA;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD SAMPLING; BODY COMPOSITION; CASE MIX; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; DIETARY INTAKE; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; HAZARD RATIO; HEALTH SURVEY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INFLAMMATION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PHOSPHATE BLOOD LEVEL; PROPORTIONAL HAZARDS MODEL; PROTEIN INTAKE; UREA NITROGEN BLOOD LEVEL;

ADULT; AGED; BIOLOGICAL MARKERS; COHORT STUDIES; DIET RECORDS; DIETARY PROTEINS; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LINEAR MODELS; MALE; MIDDLE AGED; NUTRITION POLICY; NUTRITIONAL STATUS; PHOSPHORUS, DIETARY; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 77950941643     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.08601209     Document Type: Article

References (64)

1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004 (Pubitemid 39268908)
2. Berl T, Henrich W: Kidney-heart interactions: Epidemiology, pathogenesis, and treatment. Clin J Am Soc Nephrol 1: 8-18, 2006
3. Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, Andress DL: Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease. Kidney Int 71: 31-38, 2007 (Pubitemid 44967731)
4. Brenner BM: Nephron adaptation to renal injury or ablation. Am J Physiol 249: F324-F337, 1985
5. Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, McAllister CJ, Budoff MJ, Salusky IB, Kopple JD: Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 70: 771-780, 2006 (Pubitemid 44215354)
6. Kestenbaum B, Sampson JN, Rudser KD, Patterson DJ, Seliger SL, Young B, Sherrard DJ, Andress DL: Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 16: 520-528, 2005 (Pubitemid 41725150)
7. Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G: Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112: 2627-2633, 2005 (Pubitemid 41532599)
8. Shinaberger CS, Greenland S, Kopple JD, Van Wyck D, Mehrotra R, Kovesdy CP, Kalantar-Zadeh K: Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr 88: 1511-1518, 2008
9. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15: 2208-2218, 2004 (Pubitemid 39031360)
10. Reynolds JT, Homel P, Cantey L, Evans E, Harding P, Gotch F, Wuerth D, Finkelstein S, Levin N, Kliger A, Simon DB, Finkelstein FO: A one-year trial of in-center daily hemodialysis with an emphasis on quality of life. Blood Purif 22: 320-328, 2004 (Pubitemid 39177739)
11. Nishizawa Y, Jono S, Ishimura E, Shioi A: Hyperphos-phatemia and vascular calcification in end-stage renal disease. J Ren Nutr 15: 178-182, 2005 (Pubitemid 40093705)
12. Mathew S, Tustison KS, Sugatani T, Chaudhary LR, Rifas L, Hruska KA: The mechanism of phosphorus as a cardiovascular risk factor in CKD. J Am Soc Nephrol 19: 1092-1105, 2008
13. Uribarri J: Phosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intake. Semin Dial 20: 295-301, 2007
14. Block G, Uribarri J, Coladonato JA, Fan SL, Cunningham J, Nolan CR, Qunibi WY, Lindberg JS: How should hyperphosphatemia be managed in dialysis patients? Semin Dial 15: 315-328, 2002
15. Nolan CR, Qunibi WY: Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis. Kidney Int Suppl (95): S13-S20, 2005 (Pubitemid 43361551)
16. Sullivan C, Sayre SS, Leon JB, Machekano R, Love TE, Porter D, Marbury M, Sehgal AR: Effect of food additives on hyper-phosphatemia among patients with end-stage renal disease: A randomized controlled trial. JAMA 301: 629-635, 2009
17. Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, Franch H, Guarnieri G, Ikizler TA, Kaysen G, Lindholm B, Massy Z, Mitch W, Pineda E, Stenvinkel P, Trevino-Becerra A, Wanner C: A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 73: 391-398, 2008 (Pubitemid 351186278)
18. Kalantar-Zadeh K, Gutekunst L, Mehrotra R, Kovesdy CP, Bross R, Shinaberger CS, Noori N, Hirschberg R, Benner D, Nissenson A, Kopple JD: Understanding sources of dietary phosphorus in the management of chronic kidney disease patients. Clin J Am Soc Nephrol January 21, 2010 [epub ahead of print]
19. National Kidney Foundation: K/DOQI Clinical Practice Guideli nes for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42: S1-S202, 2003
20. Bross R, Zitterkoph J, Pithia J, Benner D, Rambod M, Kovesdy CP, Kopple JD, Kalantar-Zadeh K: Association of serum total iron-binding capacity and its changes over time with nutritional and clinical outcomes in hemodialysis patients. Am J Nephrol 29: 571-581, 2009
21. Colman S, Bross R, Benner D, Chow J, Braglia A, Arzaghi J, Dennis J, Martinez L, Baldo DB, Agarwal V, Trundnowski T, Zitterkoph J, Martinez B, Khawar OS, Kalantar-Zadeh K: The Nutritional and Inflammatory Evaluation in Dialysis patients (NIED) study: Overview of the NIED study and the role of dietitians. J Ren Nutr 15: 231-243, 2005 (Pubitemid 40502093)
22. Rambod M, Bross R, Zitterkoph J, Benner D, Pithia J, Colman S, Kovesdy CP, Kopple JD, Kalantar-Zadeh K: Association of Malnutrition-Inflammation Score with quality of life and mortality in hemodialysis patients: A 5-year prospective cohort study. Am J Kidney Dis 53: 298-309, 2009
23. Shantouf R, Rambod M, Kovesdy CP, Ahmadi N, Nissen-son AR, Budoff MJ, Kalantar-Zadeh K: Association of serum alkaline phosphatase and coronary artery calcification in hemodialysis patients. Am J Kidney Dis 53: A70-A70, Meeting Abstract 190, 2009
24. Bross RCG, Kovesdy C, Oreopoulos A, Noori N, Golden S, Benner D, Kopple J, Kalantar-Zadeh K: Comparing body composition assessment tests in long-term hemodialysis patients Am J Kidney Dis 2010, in press
25. Mehrotra R, Kermah D, Fried L, Kalantar-Zadeh K, Kha-war O, Norris K, Nissenson A: Chronic peritoneal dialysis in the United States: Declining utilization despite improving outcomes. J Am Soc Nephrol 18: 2781-2788, 2007 (Pubitemid 47531206)
26. Beddhu S, Bruns FJ, Saul M, Seddon P, Zeidel ML: A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. Am J Med 108: 609-613, 2000 (Pubitemid 30336599)
27. Nelson EE, Hong CD, Pesce AL, Peterson DW, Singh S, Pollak VE: Anthropometric norms for the dialysis population. Am J Kidney Dis 16: 32-37, 1990 (Pubitemid 20298127)
28. Williams AJ, McArley A: Body composition, treatment time, and outcome in hemodialysis patients. J Ren Nutr 9: 157-162, 1999
29. Kalantar-Zadeh K, Dunne E, Nixon K, Kahn K, Lee GH, Kleiner M, Luft FC: Near infra-red interactance for nutritional assessment of dialysis patients. Nephrol Dial Transplant 14: 169-175, 1999 (Pubitemid 29041889)
30. Kalantar-Zadeh K, Kuwae N, Wu DY, Shantouf RS, Fouque D, Anker SD, Block G, Kopple JD: Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr 83: 202-210, 2006 (Pubitemid 44713179)
31. Miller JE, Kovesdy CP, Nissenson AR, Mehrotra R, Streja E, Van Wyck D, Greenland S, Kalantar-Zadeh, K: Association of hemodialysis treatment time and dose with mortality and the role of race and sex. Am J Kidney Dis 55: 100-112, 2010
32. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR: Compar- ison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347: 1557-1565, 2002 (Pubitemid 35315836)
33. Erbagci AB, Tarakcioglu M, Aksoy M, Kocabas R, Nacak M, Aynacioglu AS, Sivrikoz, C: Diagnostic value of CRP and Lp(a) in coronary heart disease. Acta Cardiol 57: 197-204, 2002 (Pubitemid 34625365)
34. Pecoits-Filho R, Barany P, Lindholm B, Heimburger O, Stenvinkel P: Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant 17: 1684-1688, 2002 (Pubitemid 35012175)
35. Beutler B, Cerami A: The biology of cachectin/TNF-a primary mediator of the host response. Annu Rev Immunol 7: 625-655, 1989 (Pubitemid 19138027)
36. Block G, Thompson FE, Hartman AM, Larkin FA, Guire KE: Comparison of two dietary questionnaires validated against multiple dietary records collected during a 1-year period. J Am Diet Assoc 92: 686-693, 1992
37. Block G, Woods M, Potosky A, Clifford C: Validation of a self-administered diet history questionnaire using multiple diet records. J Clin Epidemiol 43: 1327-1335, 1990
38. Mares-Perlman JA, Klein BE, Klein R, Ritter LL, Fisher MR, Freudenheim JL: A diet history questionnaire ranks nutrient intakes in middle-aged and older men and women similarly to multiple food records. J Nutr 123: 489-501, 1993 (Pubitemid 23084215)
39. Block G, Hartman AM, Naughton D: A reduced dietary questionnaire: development and validation. Epidemiology 1: 58-64, 1990 (Pubitemid 20255624)
40. Block G, Wakimoto P, Jensen C, Mandel S, Green RR: Validation of a food frequency questionnaire for Hispanics. Prev Chronic Dis 3: A77, 2006
41. Day N, McKeown N, Wong M, Welch A, Bingham S: Epide-miological assessment of diet: A comparison of a 7-day diary with a food frequency questionnaire using urinary markers of nitrogen, potassium and sodium. Int J Epidemiol 30: 309-317, 2001 (Pubitemid 32447833)
42. Durrleman S, Simon R: Flexible regression models with cubic splines. Stat Med 8: 551-561, 1989 (Pubitemid 19116001)
43. Kalantar-Zadeh K, Mehrotra R, Regidor DL, McAllister CJ, Kopple JD: Should serum phosphorus be controlled by decreasing dietary protein in CKD [Abstract]? Presented at the American Society of Nephrology annual conference, San Diego, CA, 2006
44. Kovesdy CP, Anderson JE, Kalantar-Zadeh K: Outcomes associated with serum phosphorus level in males with non-dialysis dependent CKD. Clin Nephrol 2010, in press
45. Menon V, Greene T, Pereira AA, Wang X, Beck GJ, Kusek JW, Collins AJ, Levey AS, Sarnak MJ: Relationship of phosphorus and calcium-phosphorus product with mortality in CKD. Am J Kidney Dis 46: 455-463, 2005 (Pubitemid 41208181)
46. Kalantar-Zadeh K, Kopple JD, Deepak S, Block D, Block G: Food intake characteristics of hemodialysis patients as obtained by food frequency questionnaire. J Ren Nutr 12: 17-31, 2002
47. Kooienga L: Phosphorus balance with daily dialysis. Semin Dial 20: 342-345, 2007
48. Kovesdy CP, Kalantar-Zadeh K: Bone and mineral disorders in pre-dialysis CKD. Int Urol Nephrol 40: 427-440, 2008
49. Slinin Y, Foley RN, Collins AJ: Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: The USRDS waves 1, 3, and 4 study. J Am Soc Nephrol 16: 1788-1793, 2005 (Pubitemid 41716485)
50. Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK: Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 12: 2131-2138, 2001 (Pubitemid 32880350)
51. Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke SK, Chertow GM: Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 39: 695-701, 2002 (Pubitemid 34158168)
52. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342: 1478-1483, 2000 (Pubitemid 30318271)
53. Amann K, Ritz E, Wiest G, Klaus G, Mall G: A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia. J Am Soc Nephrol 4: 1814-1819, 1994 (Pubitemid 24976985)
54. Qing DP, Ding H, Vadgama J, Wu YY, Kopple JD: Elevated myocardial cytosolic calcium impairs insulin-like growth factor-1-stimulated protein synthesis in chronic renal failure. J Am Soc Nephrol 10: 84-92, 1999 (Pubitemid 29034946)
55. Massry SG, Fadda GZ: Chronic renal failure is a state of cellular calcium toxicity. Am J Kidney Dis 21: 81-86, 1993 (Pubitemid 23062779)
56. Stack AG, Saran R: Clinical correlates and mortality impact of left ventricular hypertrophy among new ESRD patients in the United States. Am J Kidney Dis 40: 1202-1210, 2002 (Pubitemid 35403132)
57. Watson KE, Abrolat ML, Malone LL, Hoeg JM, Doherty T, Detrano R, Demer LL: Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 96: 1755-1760, 1997 (Pubitemid 27400730)
58. Loghman-Adham M: Adaptation to changes in dietary phosphorus intake in health and in renal failure. J Lab Clin Med 129: 176-188, 1997 (Pubitemid 27134062)
59. Slatopolsky E, Finch J, Denda M, Ritter C, Zhong M, Dusso A, MacDonald PN, Brown AJ: Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest 97: 2534-2540, 1996 (Pubitemid 26187341)
60. Gutierrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Juppner H, Wolf M: Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359: 584-592, 2008
61. Collins AJ, Kasiske B, Herzog C, Chavers B, Foley R, Gil-bertson D, Grimm, R, Liu J, Louis T, Manning W, Matas A, McBean M, Murray A, St Peter W, Xue J, Fan Q, Guo H, Li S, Li S, Roberts T, Snyder J, Solid C, Wang C, Weinhandl E, Arko C, Chen SC, Dalleska F, Daniels F, Dunning S, Ebben J, Frazier E, Johnson R, Sheets D, Forrest B, Berrini D, Constantini E, Everson S, Frederick P, Eggers P, Agodoa L; United States Renal Data System. Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States. Am J Kidney Dis 45(1 Suppl 1): A5-A7, S1-S280, 2005 (Pubitemid 40091716)
62. Isakova T, Gutierrez OM, Chang Y, Shah A, Tamez H, Smith K, Thadhani R, Wolf M: Phosphorus binders and survival on hemodialysis. J Am Soc Nephrol 20: 388-396, 2009
63. Kloppenburg WD, Stegeman CA, Hooyschuur M, van der Ven J, de Jong PE, Huisman RM: Assessing dialysis adequacy and dietary intake in the individual hemodialysis patient. Kidney Int 55: 1961-1969, 1999 (Pubitemid 29197985)
64. Calvo MS, Carpenter TO: The influence of phosphorus on the skelton. In: Nutritional Aspects of Bone Health, 5th Ed., edited by New SA, Bonjour JP, Cambridge UK, The Royal Society of Chemistry, 2003, p 253